ⓘ Sofituzumab vedotin

                                     

ⓘ Sofituzumab vedotin

Sofituzumab vedotin is a monoclonal antibody designed for the treatment of ovarian cancer.

This drug developed by Genentech / Roche.

                                     
  • Examples: Sofituzumab vedotin Polatuzumab vedotin RG7596 Enfortumab vedotin Pinatuzumab vedotin Lifastuzumab vedotin Brentuximab vedotin Glembatumumab
  • Commercialization Rights for RENCAREX NCI Drug Dictionary: Glemtumumab vedotin Results from Cure Brain Cancer Foundation - funded trial show promise